[HTML][HTML] Role of the humoral immune response during COVID-19: guilty or not guilty?
M Yaugel-Novoa, T Bourlet, S Paul�- Mucosal Immunology, 2022 - Elsevier
Systemic and mucosal humoral immune responses are crucial to fight respiratory viral
infections in the current pandemic of COVID-19 caused by the SARS-CoV-2 virus. During�…
infections in the current pandemic of COVID-19 caused by the SARS-CoV-2 virus. During�…
[HTML][HTML] Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or�…
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or�…
[HTML][HTML] Severe COVID-19: what have we learned with the immunopathogenesis?
B Bordallo, M Bellas, AF Cortez, M Vieira…�- Advances in�…, 2020 - SciELO Brasil
The COVID-19 outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has become a global major concern. In this review, we addressed a theoretical�…
CoV-2) has become a global major concern. In this review, we addressed a theoretical�…
[HTML][HTML] Cellular immune response to COVID-19 and potential immune modulators
X Zhou, Q Ye�- Frontiers in Immunology, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as�…
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as�…
[HTML][HTML] Innate immunity: the first line of defense against SARS-CoV-2
MS Diamond, TD Kanneganti�- Nature immunology, 2022 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus (SARS-CoV)-2, continues to cause substantial morbidity�…
respiratory syndrome coronavirus (SARS-CoV)-2, continues to cause substantial morbidity�…
[HTML][HTML] A longitudinal study of immune cells in severe COVID-19 patients
D Payen, M Cravat, H Maadadi, C Didelot…�- Frontiers in�…, 2020 - frontiersin.org
Little is known about the time-dependent immune responses in severe COVID-19. Data of
15 consecutive patients were sequentially recorded from intensive care unit admission�…
15 consecutive patients were sequentially recorded from intensive care unit admission�…
[HTML][HTML] COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
A Bonifacius, S Tischer-Zimmermann, AC Dragon…�- Immunity, 2021 - cell.com
Cellular and humoral immunity to SARS-CoV-2 is critical to control primary infection and
correlates with severity of disease. The role of SARS-CoV-2-specific T cell immunity, its�…
correlates with severity of disease. The role of SARS-CoV-2-specific T cell immunity, its�…
T cell immunity to SARS-CoV-2 following natural infection and vaccination
SARS-CoV-2 first emerged in the human population in late 2019 in Wuhan, China, and in a
matter of months, spread across the globe resulting in the Coronavirus Disease 19 (COVID�…
matter of months, spread across the globe resulting in the Coronavirus Disease 19 (COVID�…
[HTML][HTML] Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
SA Lowery, A Sariol, S Perlman�- Cell Host & Microbe, 2021 - cell.com
COVID-19 can result in severe disease characterized by significant immunopathology that is
spurred by an exuberant, yet dysregulated, innate immune response with a poor adaptive�…
spurred by an exuberant, yet dysregulated, innate immune response with a poor adaptive�…
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the�…
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the�…